When a "quality measure" may not be what it seems: the national committee for quality assurance report and hypertension control [0.03%]
质量改善措施可能并不像看上去的那样：NCQA报告和高血压控制
John W Graves,Sheldon G Sheps
John W Graves
Roundtable discussion: blood pressure goal attainment: meeting the challenge of the JNC 7's blood pressure goals and the role of renin-angiotensin-aldosterone system blockade [0.03%]
圆桌讨论：血压达标——迎接JNC 7指南提出的挑战及肾素-血管紧张素-醛固酮系统阻断的作用
Michael Weber,Jan Basile,Joseph Izzo Jr et al.
Michael Weber et al.
This roundtable discussion, held in December 2003, was convened to discuss the impact of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure's (JNC 7) challenging blo...
Metabolic properties of vasodilating beta blockers: management considerations for hypertensive diabetic patients and patients with the metabolic syndrome [0.03%]
血管扩张型β受体阻滞剂的代谢特征及其在高血压糖尿病患者和具有代谢综合征患者的临床应用考虑因素
Stephan Jacob,Erik J Henriksen
Stephan Jacob
Type 2 diabetes and hypertension are both insulin-resistant states that impose an excessive risk burden for future major cardiovascular events, including coronary heart disease, stroke, and heart failure. beta-adrenergic receptor antagonist...
Different effects of losartan and moxonidine on endothelial function during sympathetic activation in essential hypertension [0.03%]
在原发性高血压交感神经激活时，氯沙坦和莫昔胜对内皮功能的不同影响
Michael N Doumas,Stella N Douma,Kostas M Petidis et al.
Michael N Doumas et al.
The aim of this study was to investigate: 1) the effects of treadmill exercise on plasma catecholamines and endothelin-1 (ET-1, a potent vasoconstrictor) levels in hypertensive patients; and 2) the impact of 1-month therapy with losartan as...
Trends in hypertension-related death in the United States: 1980-1998 [0.03%]
美国高血压相关死亡率变化情况(1980～1998年)
Carma Ayala,Janet B Croft,Wendy A Wattigney et al.
Carma Ayala et al.
Trends in hypertension-related mortality for groups by race/ethnicity, sex, and age have not been examined previously. National multiple-cause mortality files for 1980-1998 were analyzed for adult decedents with hypertension listed as one o...
Thomas G Pickering
Thomas G Pickering
Matthew R Weir
Matthew R Weir
The relationship between dietary salt, blood pressure, and risk for cardiovascular disease has been debated for decades. Microalbuminuria is a biomarker for both cardiovascular and kidney disease. The presence of microalbuminuria correlates...
George L Bakris
George L Bakris
Albuminuria is recognized in all hypertension guideline statements as a cardiovascular risk factor and indicator of kidney disease. Recent data also demonstrate a strong association between the presence of microalbuminuria and elevations in...
Katherine R Tuttle
Katherine R Tuttle
Microalbuminuria is a major independent risk factor for cardiovascular disease (CVD) events in persons with diabetes or hypertension, the general population, and persons with known CVD. Although microalbuminuria is a stronger risk factor in...